دورية أكاديمية

Decreased SATB1 expression promotes AML cell proliferation through NF-κB activation

التفاصيل البيبلوغرافية
العنوان: Decreased SATB1 expression promotes AML cell proliferation through NF-κB activation
المؤلفون: Xiaodan Luo, Lihua Xu, Xiaohong Wu, Huo Tan, Lian Liu
المصدر: Cancer Cell International, Vol 19, Iss 1, Pp 1-11 (2019)
بيانات النشر: BMC, 2019.
سنة النشر: 2019
المجموعة: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC:Cytology
مصطلحات موضوعية: SATB1, Acute myeloid leukemia, Gene expression profiling, RNA interference, NF-κB, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Cytology, QH573-671
الوصف: Abstract Background Special AT-rich sequence-binding protein 1 (SATB1) is a chromatin-remodeling protein that regulates gene expressions in different types of cancer. Up-regulation of SATB1 is linked with progression of tumors. Our previous study showed that SATB1 expression was decreased in T cell leukemia/lymphoma. The contrary roles of SATB1 in solid organ tumors and hematology malignancy may provide hints to study the function of SATB1. Methods To characterize SATB1 mRNA and protein expression in acute myeloid leukemia (AML), we performed qRT-PCR and Western blot on bone marrow mononuclear cells from 52 newly diagnosed AML patients. Stable HL-60 cell lines with knockdown of SATB1 by shRNAs sequences (HL-60 SATB1-shRNA1 and HL-60 SATB1-shRNA2) were established. Cell proliferation, cell cycle and cell invasiveness were analyzed. Murine model was established using HL-60 SATB1-shRNAs treated nude mice and tumorigenicity was compared to study the role of SATB1 in vivo. Global gene expression profiles were analyzed in HL-60 cells with SATB1 knockdown to investigate the mechanisms underlying the regulation of AML cell growth by SATB1. Results We found that SATB1 expression was significantly decreased in patients with AML compared to normal control, and was increased after complete remission of AML. Knockdown of SATB1 enhanced the proliferation of HL-60 cells and accelerated S phase entry in vitro, and promoted the tumor growth in vivo. Global gene expression profiles were analyzed in HL-60 cells with SATB1 knockdown and the differentially expressed genes were involved in NF-κB, MAPK and PI3 K/Akt signaling pathways. Nuclear NF-κB p65 levels were significantly increased in SATB1 depleted HL-60 cells. Conclusions Decreased SATB1 expression promotes AML cell proliferation through NF-κB activation. SATB1 could be a predictor for better response to treatment in AML.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1475-2867
80863094
Relation: http://link.springer.com/article/10.1186/s12935-019-0850-x; https://doaj.org/toc/1475-2867
DOI: 10.1186/s12935-019-0850-x
URL الوصول: https://doaj.org/article/492dd80863094cbe8fc0c84f0bb676d8
رقم الأكسشن: edsdoj.492dd80863094cbe8fc0c84f0bb676d8
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:14752867
80863094
DOI:10.1186/s12935-019-0850-x